Struggle for Access to Glivec

Struggle for Access to Glivec
in South Korea
Solidarity Needed Now!!!

Table of Content
– The Beginning: Struggle for Rights of Access to Glivec, Extremely High-Priced Drug
– Excluding Chronic Stage CML Patients out of NHI
– Disapproval of Korean National Health Insurance Price and Temporal Suspension of Glivec Supply in the Market
– What is the problem? Priceless Glivec Kills CML Patients
– What is the problem? Are you asking 30 times of production costs, Novartis?
– What is the problem? Glivec, the Product of Public R&D
– What is the problem? Exclusion of Chronic Phase CML from NHI, High Co-payment Rate; Patients are Urged to Death.
– Significance of Struggle for Access to Glivec : Struggle Stopping Murder by Patent
– Significance of Struggle for Access to Glivec : First Struggle for Access to Medicine: Patients’ Initiative
– Significance of Struggle for Access to Glivec : Struggle for Access to Glivec: Global Agenda, not South Korean
– Solidarity Needed!! Novartis Should Lower the Price Patients Can Afford Glivec
– Solidarity Needed!! Chronic Phase CML Should be Covered by NHI, and Co-payment Rate Should be Cut Down
– Solidarity Needed!! Attempt at Compulsory License after Brazilian one

 

2003-09-24